Nephro Care India share price
NSE: NEPHROCAREHealthcare Services
Last close ₹83.00down ₹2.95 (3.43%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹85.95.
52-week range of traded prices to 23 Oct 2026
₹50.05Low, 30 Mar 2026₹156.35High, 18 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹137 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, NSEVolume. Shares traded on the last trading day.
- 19,200
Results
Standalone, as consolidated accounts are on record for only 1 of the last ten years; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 8 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹29 Crup 9.12%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹1.61 Crup 60.09%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 5.5%
Revenue by year
Peak revenue ₹89 Cr, year to Mar 2026
Net profit by year, a loss in red
| ₹ crore | Dec 2025Filed 13 Feb | Mar 2026Filed 27 May | Jun 2026Filed 8 Aug |
|---|---|---|---|
| Revenue | 22.7 | 26.7 | 29.2 |
| Net profit | 0.4 | 1.0 | 1.6 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 1.9% | 3.8% | 5.5% |
Standalone. The quarters from Sep 2024, the first on record, but for those filed as half years, which are below. The latest is shaded. No results on record for the quarter to Sep 2024.
| ₹ crore | Sep 2024Filed 28 May | Mar 2025Filed 28 May | Sep 2025Filed 12 Nov |
|---|---|---|---|
| Revenue | 17.7 | 28.3 | 39.3 |
| Net profit | 2.2 | 1.5 | 1.9 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 12.4% | 5.1% | 4.9% |
Standalone. The half years in the same span that the quarters on record do not fully cover.
Business segments
Share of revenue, year to Mar 2026, consolidated.Segment revenue and profit
- Income from IPD ServicesIncome from IPD Services, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹43.3 Cr48.7%
- Income from OPD ServicesIncome from OPD Services, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹25.2 Cr28.4%
- Income from sale of medicines from pharmacyIncome from sale of medicines from pharmacy, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹20.4 Cr22.9%
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −59.3% | −7.4% | −56.0% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 1 year is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Peers and competitors
Hospital, 38 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Nephro Care India in market cap.
Nephro Care India is not on the chart: it has no P/E or return on equity today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Asarfi HospitalASARFI | 335 | 20.1 | 3.4 | – | +43.2% | +57.5% | 18.7% | – | 0.00% |
 Lotus Eye Hospital and InstituteLOTUSEYE | 234 | 1,565.6 | 3.9 | 49.7 | +14.1% | −77.4% | 0.2% | 0.4% | 0.00% |
 Aashka HospitalsAASHKA | 217 | 64.9 | 2.1 | – | +1.6% | +2.2% | 3.3% | – | 0.00% |
 Hannah Joseph HospitalHANNAH | 209 | 18.7 | 2.1 | 7.6 | – | – | 11.5% | 14.9% | 2.17% |
 Abate As IndustriesABATEAS | 107 | 8.7 | 0.6 | 8.0 | – | – | 7.3% | 5.7% | 0.00% |
 Maitreya MedicareMAITREYA | 98 | – | 3.5 | – | −2.5% | −2,152.0% | −11.3% | – | 0.00% |
 Sangani HospitalsSANGANI | 82 | 27.5 | 2.0 | – | +404.9% | +15.5% | 7.8% | – | 0.00% |
 Fortis Malar HospitalsFORTISMLR | 75 | 550.9 | 2.2 | – | +49.3% | −97.0% | 0.4% | −4.6% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
Aug 2026
Nephro Care India share price by year
Each calendar year to 2025.Nephro Care India share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 110.50 | −39.9% | 202.65 | 105.70 |
| 2024 | 184.00 | – | 360.80 | 179.55 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2024 is from its first session, 5 Jul 2024.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 85.00 | 85.00 | 78.40 | 83.00 | 81.30 | 19,200 | – |
| 22 Oct 2026 | 85.50 | 85.95 | 83.60 | 85.95 | 84.45 | 10,400 | 92.3% |
| 21 Oct 2026 | 85.00 | 86.80 | 85.00 | 85.50 | 85.77 | 15,600 | 84.6% |
| 19 Oct 2026 | 88.00 | 88.00 | 85.00 | 85.00 | 85.64 | 8,800 | 81.8% |
| 16 Oct 2026 | 85.00 | 86.95 | 83.10 | 86.00 | 85.32 | 4,400 | 72.7% |
| 15 Oct 2026 | 85.70 | 87.45 | 85.05 | 85.40 | 86.32 | 9,600 | 54.2% |
| 14 Oct 2026 | 88.00 | 88.00 | 82.60 | 85.70 | 84.08 | 37,600 | 69.2% |
| 13 Oct 2026 | 86.00 | 87.60 | 85.00 | 86.50 | 86.36 | 9,600 | 75.0% |
| 12 Oct 2026 | 84.00 | 87.70 | 83.15 | 83.85 | 85.55 | 22,000 | 78.2% |
| 9 Oct 2026 | 82.70 | 84.95 | 82.05 | 83.95 | 83.87 | 16,400 | 68.3% |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Nephro Care India Limited
- NSE symbol
- NEPHROCARE
- ISIN
- INE0SUN01013
- Industry
- Healthcare Services
- Listed
- Jul 2024
- Face value
- ₹10